| Dr Michael Bradley Burton, DO | |
|
934 S Main St Ste 8, Layton, UT 84041-7136 | |
| (801) 773-8644 | |
| (801) 773-9828 |
| Full Name | Dr Michael Bradley Burton |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 934 S Main St Ste 8, Layton, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760822423 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 9685328 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Bradley Burton, DO 934 S Main St Ste 8, Layton, UT 84041-7136 Ph: (801) 773-8644 | Dr Michael Bradley Burton, DO 934 S Main St Ste 8, Layton, UT 84041-7136 Ph: (801) 773-8644 |
News Archive
High intersection density and well-connected streets in towns and cities may discourage children from being active and exercising outdoors, according to a Queen's University study.
The study by the National Institute of Mental Health (NIMH) intended to examine the effectiveness of a type of treatment advocated by some autism activists as alternative medical therapy for children with the condition.
The U.S. government Thursday released a six-year strategy to address malaria globally, Reuters reports (Fox, 4/22). The plan was issued through the President's Malaria Initiative (PMI) in conjunction with World Malaria Day, April 25, and is a "core component of President [Barack] Obama's Global Health Initiative," according to a USAID press release (4/22).
The National Nanotechnology Initiative (NNI) today published the report from the workshop, "Stakeholder Perspectives on Perception, Assessment, and Management of the Potential Risks of Nanotechnology" (R3 Workshop), which was held September 10-11, 2013, in Washington, D.C.
LifeCycle Pharma A/S today announced receipt of agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment of its pivotal Phase 3 study, Study 3002, for LCP-Tacro in patients, who have just received a kidney transplant.
› Verified 7 days ago
Michael Patrick Husseman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2084 N 1700 W, Suite A, Layton, UT 84041 Phone: 801-773-8644 Fax: 801-773-9828 | |
Joshua Mcbride, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2075 University Park Blvd, Layton, UT 84041 Phone: 801-779-6200 | |
Jennifer M Gilsoul, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2084 N 1700 W, Suite A, Layton, UT 84041 Phone: 801-773-8644 Fax: 801-773-9828 | |
Colton Lee Ragsdale, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2084 N 1700 W, Suite A, Layton, UT 84041 Phone: 801-773-8644 Fax: 801-927-1591 | |
Frank D Kramer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 | |
Dr. Mari Suto Luce, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2244 E 3500 N, Layton, UT 84040 Phone: 801-387-4500 | |
Steven Jonathan Williams, Pediatrics Medicare: Medicare Enrolled Practice Location: 3225 W Gordon Ave Ste 1, Layton, UT 84041 Phone: 801-397-6150 |